Trial Comparing Alignment Techniques - RSA of ATTUNE Knee System

December 19, 2023 updated by: Canadian Radiostereometric Analysis Network

Radiostereometric Analysis (RSA) of the ATTUNE Knee System: A Randomized Controlled Trial Comparing Anatomic (Femur First) to Neutral Mechanical Alignment Techniques

The purpose of this study is to compare migration patterns between mechanical and anatomic alignment surgical techniques for the Attune S+ CR-FB knee system using model-based RSA over the first 2 post-operative years.

Study Overview

Detailed Description

This is a multi-centre, randomized controlled trial of patients undergoing cruciate-retaining total knee arthroplasty with the Attune S+ fixed bearing TKR system. Patients will be randomized to two study groups:

  1. Neutral mechanical alignment;
  2. Anatomical alignment.

The principal objective of this study is to compare migration patterns between mechanical and anatomic alignment surgical techniques for the Attune S+ CR-FB knee system using model-based RSA over the first 2 post-operative years.

Secondary objectives include; comparison of 2-year migration values against published thresholds for adequate short-term fixation, comparison of functional and health status of subjects following surgery, comparison of intra-operative soft-tissue releases, incidence of complications and adverse events, and to assess several health economic parameters relating to the surgery.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R2K 3S8
        • Concordia Hospital
    • Ontario
      • London, Ontario, Canada, N6A 5W9
        • London Health Sciences Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Symptomatic osteoarthritis of the knee indicating primary total knee arthroplasty
  2. Varus knee deformity of 0 to 10 degrees
  3. Sufficient ligamentous function to warrant retention of the posterior cruciate ligament
  4. Between the ages of 21 and 80 inclusive
  5. Patients willing and able to comply with follow-up requirements and self-evaluations
  6. Ability to give informed consent

Exclusion Criteria:

  1. Active or prior infection
  2. Medical condition precluding major surgery
  3. Inflammatory arthropathy
  4. Prior patellectomy
  5. PCL deficiency
  6. Major Coronal plane deformity
  7. Valgus alignment
  8. Bone defects requiring augments, cones and/or stemmed implants
  9. Body Mass Index 45 or more

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Neutral Mechanical Alignment
Total knee arthroplasty: Neutral Mechanical Alignment vs Anatomical Alignment
Hip-knee-ankle angle of 180° ± 3°.
Active Comparator: Anatomical Alignment
Total knee arthroplasty: Neutral Mechanical Alignment vs Anatomical Alignment
Restoring a patient's pre-diseased limb alignment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant migration
Time Frame: 2 years
Measured via radiosteriometric analysis (RSA)
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital stay
Time Frame: Up to 1 week
Number of days in hospital
Up to 1 week
Oxford-12 knee score
Time Frame: Pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years
The Oxford Knee Score (OKS) is a patient self-administered 12-item questionnaire with each question having a Likaert-like response option. Each item is scored from 0 to 4, and the items are summated, with lower total scores indicating poorer performance. The OKS measures pain and general activities of daily living.
Pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years
Pain Catastrophizing Scale (PCS)
Time Frame: Pre-operative, 12 months
The patient are asked to indicate the degree to which they have the above thoughts and feelings when they are experiencing pain. Each PCS item is rated on a 5-point scale: 0 (not at all) to 4 (all the time). The PCS total score is computed by summing responses to the 13 items. PCS total scores range from 0 - 52.
Pre-operative, 12 months
European Quality of Life (EQ-5D-5L)
Time Frame: Pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in functional outcomes assessments. The EuroQol 5D 5L questionnaire is a standardized instrument for use as a measure of generic health status - completed by the subject. The EQ5D uses a Likert scale which assesses five states (mobility, self care, usual care, pain and discomfort and anxiety and depression) at five different levels - none(0), slight(1), moderate(2), severe(3) or unable to perform(5). Levels are coded 1-5 and an index score is then generated.
Pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years
Pre-operative Patient's Knee Implant Performance (PKIP)
Time Frame: Pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years
The Pre-surgical and/or Post-surgical Patient's Knee Implant Performance (PKIP) questionnaire is a patient reported questionnaire that consists of 24 questions relating to the patient's awareness of their knee. Questions include the patient's self-confidence about the current status of their knee performance, stability, and overall satisfaction. Each question has a 5, 6 or 10 Likaert- like response option.
Pre-operative, 6 weeks, 3 months, 6 months, 1 year, 2 years
7. University of California at Los Angeles (UCLA) Activity Level scale
Time Frame: Pre-operative, 6 months, 1 year, 2 years
Evaluate and compare the change in UCLA activity score compared to baseline in the study cohort. UCLA activity scores range from 1 to 10, and is a measure of activity with 10 being most active.
Pre-operative, 6 months, 1 year, 2 years
Pain VAS
Time Frame: Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year, 2 Years
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported satisfaction as measured using the visual analogue scale (VAS) from 0 (No pain) - 100 (Worst pain imaginable)
Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year, 2 Years
Patient satisfaction: VAS
Time Frame: Preoperative, 3 Months, 6 Months, 1 Year, 2 Years
Evaluate and compare the change from preoperative to 2 years between the study groups timepoints in patient reported pain severity as measured using the visual analogue scale (VAS) from 0 (Unsatisfied) - 100 (Completely satisfied)
Preoperative, 3 Months, 6 Months, 1 Year, 2 Years
Patient complications
Time Frame: Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year, 2 Years
Evaluate the type and frequency of the complications/adverse events.
Preoperative, 6 Weeks, 3 Months, 6 Months, 1 Year, 2 Years
Tourniquet time
Time Frame: Intraoperative
Length of time tourniquet was applied (minutes)
Intraoperative
Length of surgery
Time Frame: Intraoperative
Length of surgery, from open to closing of incision (minutes)
Intraoperative
Blood loss
Time Frame: Intraoperative
Amount of blood loss during the procedure (mL)
Intraoperative
Anesthesia type
Time Frame: Intraoperative
Anesthesia methods (general, spinal, epidural, TXA)
Intraoperative
Peri-operative pain management
Time Frame: Intraoperative
A tabulation of the pain management (Peri-Articular Injection, Femoral Nerve Block, Add. Canal Block or none) used during the procedure.
Intraoperative
Soft tissue release
Time Frame: Intraoperative
A tabulation of the tissue released during the procedure (MCL, LCL, PCL, Posterior Capsule Release).
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Turgeon, Concordia Joint Replacement Group

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 5, 2019

Primary Completion (Actual)

February 1, 2022

Study Completion (Actual)

February 1, 2022

Study Registration Dates

First Submitted

July 17, 2019

First Submitted That Met QC Criteria

September 4, 2019

First Posted (Actual)

September 6, 2019

Study Record Updates

Last Update Posted (Estimated)

December 20, 2023

Last Update Submitted That Met QC Criteria

December 19, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • B2018-139

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Neutral Mechanical Alignment

3
Subscribe